These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 35702792)
1. The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells. Huang JZ; Li LL; Tan XY; Wu ZY; Chen DW; Luo X Curr Pharm Des; 2022; 28(26):2161-2166. PubMed ID: 35702792 [TBL] [Abstract][Full Text] [Related]
2. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells. Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827 [TBL] [Abstract][Full Text] [Related]
3. Study on the effect of 5-aminolevulinic acid-mediated photodynamic therapy combined with cisplatin on human ovarian cancer OVCAR-3 cells. Lv H; Suo Y; Sun Q; Fan J; Wang Q Adv Med Sci; 2023 Mar; 68(1):147-156. PubMed ID: 36965469 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax. Liu X; Dong J; Cai W; Pan Y; Li R; Li B Int J Gynecol Cancer; 2017 Oct; 27(8):1596-1601. PubMed ID: 28692636 [TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and p53-dependent apoptosis in ovarian cancer cells. Akeshima R; Kigawa J; Takahashi M; Oishi T; Kanamori Y; Itamochi H; Shimada M; Kamazawa S; Sato S; Terakawa N Br J Cancer; 2001 Jun; 84(11):1551-5. PubMed ID: 11384107 [TBL] [Abstract][Full Text] [Related]
6. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells. Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147 [TBL] [Abstract][Full Text] [Related]
7. YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression. Mir R; Stanzani E; Martinez-Soler F; Villanueva A; Vidal A; Condom E; Ponce J; Gil J; Tortosa A; Giménez-Bonafé P Gynecol Oncol; 2014 Jan; 132(1):211-20. PubMed ID: 24262875 [TBL] [Abstract][Full Text] [Related]
8. HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells. Kou X; Yang X; Zhao Z; Li L Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):356-365. PubMed ID: 38419499 [TBL] [Abstract][Full Text] [Related]
9. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells]. Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028 [TBL] [Abstract][Full Text] [Related]
10. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
11. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. Kim JH; Jeong SJ; Kim B; Yun SM; Choi DY; Kim SH J Pineal Res; 2012 Mar; 52(2):244-52. PubMed ID: 22050627 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts. Shimada M; Kigawa J; Kanamori Y; Itamochi H; Takahashi M; Kamazawa S; Sato S; Terakawa N Eur J Cancer; 2000 Sep; 36(14):1869-75. PubMed ID: 10974636 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells. Takahashi M; Kigawa J; Minagawa Y; Itamochi H; Shimada M; Kamazawa S; Sato S; Akeshima R; Terakawa N Eur J Cancer; 2000 Sep; 36(14):1863-8. PubMed ID: 10974635 [TBL] [Abstract][Full Text] [Related]
14. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines. Tsuruta Y; Mandai M; Konishi I; Kuroda H; Kusakari T; Yura Y; Hamid AA; Tamura I; Kariya M; Fujii S Eur J Cancer; 2001 Mar; 37(4):531-41. PubMed ID: 11267864 [TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency. Li N; Chu Y; Yao L; Ying X; Jiang H; Zhou M; Xu C J Cancer Res Clin Oncol; 2011 Oct; 137(10):1455-61. PubMed ID: 21809030 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. Zhang C; Wang M; Shi C; Shi F; Pei C Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro. Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688 [TBL] [Abstract][Full Text] [Related]
18. [Effects of Diallyl Disulfide on the Proliferation and Apoptosis of Epithelial Ovarian Cancer Cells by Inducing G2/M Arrest]. Zhang RT; Shi HR; Ren F; Liu ZY; Ji PC Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):43-52. PubMed ID: 30837041 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation. Mansouri A; Zhang Q; Ridgway LD; Tian L; Claret FX Oncol Res; 2003; 13(6-10):399-404. PubMed ID: 12725530 [TBL] [Abstract][Full Text] [Related]
20. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]